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Abstract  
Arterial spin labeling (ASL) is an MR imaging technique used to assess 
cerebral blood flow (CBF) non-invasively by magnetically labeling inflowing 
blood. In this article we review the main labeling techniques, notably pulsed 
and pseudo-continuous ASL as well as emerging clinical applications. In 
dementia, the pattern of hypoperfusion on ASL closely matches the 
established patterns of hypometabolism on FDG-PET due to the close 
coupling of perfusion and metabolism in the brain. This suggests that ASL 
might be considered as an alternative for FDG, reserving PET to be used for 
the molecular disease-specific amyloid and tau tracers. In stroke, ASL can be 
used to assess perfusion alterations both in the acute and the chronic phase. 
In arteriovenous malformations and dural arteriovenous fistulas, ASL is very 
sensitive to detect even small degrees of shunting. In epilepsy, ASL can be 
used to assess the epileptogenic focus, both in the peri- and inter-ictal period. 
In neoplasms, ASL is of particular interest in cases in which gadolinium-based 
perfusion is contraindicated (e.g., allergy, renal impairment) and holds 
promise to differentiate tumor progression from benign causes of 
enhancement. Finally, various neurologic and psychiatric diseases including 
mild traumatic brain injury or posttraumatic stress disorder display alterations 
on ASL images in the absence of visualized structural changes. In the final 
part, we review current limitations and future developments of ASL techniques 
to improve clinical applicability, such as multiple inversion time ASL 
sequences to assess alterations of transit time, reproducibility and 
quantification of CBF, and to measure cerebrovascular reserve. 
Abbreviations 
AD   Alzheimer disease 
ASL  arterial spin labeling 
BOLD  blood oxygen level-dependent (effect) 
CT  computed tomography 
CTP  computed tomography perfusion 
DSC  dynamic susceptibility contrast (perfusion) 
EPI  echo planar imaging 
FDG   18F-2-fluoro-2-deoxy-D-glucose 
GRASE  gradient and spin echo  
MCI  mild cognitive impairment 
MRI  magnetic resonance imaging 
MT  magnetization transfer  
PET  positron emission tomography 
PLD  post-labelling delay  
relCBF  relative cerebral blood flow   
RF  radio-frequency  
SNR  signal to noise ratio  
TI   inflow time 
 
Introduction 
Arterial spin labeling (ASL) is an MR imaging technique that enables the 
measurement of brain perfusion non-invasively at the tissue level. Benefiting 
from the contrast of inflowing magnetically-labeled blood, ASL obviates the 
need for an exogenous contrast agent. Although the principle of ASL was 
introduced in early 1990s (1-3) and is feasible on low-field MR systems, ASL 
greatly benefits from the improved signal-to-noise ratio (SNR) of modern high-
field MRI systems (4). The increasing availability of 3T scanners as well as 
the development of improved pulse sequences and multi-channel receiver 
array coils has led to a rapidly growing interest in ASL within the past few 
years, paving the way for widespread application in neurological and 
psychiatric disorders. The current review will start by briefly summarizing the 
essential technical requirements, and then discuss in more detail emerging 
clinical applications of ASL (such as dementia, stroke, vascular 
malformations, epilepsy, tumors and psychiatry), and concludes with a critical 
review of the current limitations and future perspectives of brain ASL imaging.  
 
 
Essential technical considerations 
Basic Concepts of ASL 
ASL is based on the principle of magnetically labeling inflowing arterial blood 
protons prior to their entry into the tissue of interest. As such, it can be viewed 
as a tracer technique (5, 6), with water acting as the natural endogenous 
tracer to estimate tissue perfusion. The label is created by applying radio-
frequency (RF) pulses to invert the bulk magnetization of the blood water 
protons. Images are acquired after the labeling and inflow period using rapid 
acquisition techniques such as echo-planar imaging (EPI), gradient and spin 
echo (GRASE) imaging, or 3-dimensional fast spin-echo (3D-FSE) imaging 
using a stack-of-spirals approach (7-9). A pair of images is always acquired: a 
labeled image, in which the blood water magnetization is inverted, and a 
control image, in which the blood water magnetization is not inverted. The 
signal difference between labeled and control images is proportional to the 
amount of magnetization inverted and delivered to the tissue. If all the labeled 
blood has arrived at the imaging voxel at the time of image acquisition, the 
signal difference will be proportional to cerebral blood flow (CBF). The current 
main implementations of ASL are pulsed and pseudo-continuous labeling. 
 
Pulsed ASL 
In PASL, the arterial blood water is labeled using a short adiabatic inversion 
pulse. The labeling pulses are on the order of ~10ms and designed to invert 
the blood water instantaneously in a particular region, typically located inferior 
to the brain (Figure 1A). After labeling, a post-label delay period is required 
(also known as the inflow time or TI for PASL), during which time the inverted 
blood moves from the labeling region into the brain, loosing gradually its label 
through longitudinal T1 relaxation. For this reason, PASL is intrinsically a 
lower SNR technique than is pseudo-continuous ASL (pCASL). The control 
acquisition for PASL consists of applying an RF pulse with equivalent power 
to the labeling pulse, but which has a net zero effect on the blood water 
magnetization in the labeling region. 
 
Pseudo-continuous ASL 
In pCASL, a long labeling period (1-2 sec) is made up of a train of very short 
(≈1ms) pulses (9). This train of short pulses is designed to invert the inflowing 
blood magnetization in an adiabatic or pseudo steady-state manner (Figure 
1B). It is useful to think of the blood being continuously inverted as it flows 
through a ‘labeling plane’ in the inferior-superior direction. If the phase of 
every second pulse in the pCASL pulse train is shifted by 180, the flowing 
blood water is minimally perturbed, and thus enables acquisition of non-
labeled control images. pCASL has recently been adopted as the labeling 
method of choice for clinical imaging, due to its ease of implementation and 
high SNR (10). 
 
Pros and cons: PASL vs pCASL 
The main advantage of pCASL over PASL is its higher SNR - a substantial 
benefit in a technique that is intrinsically SNR-limited. The reason for this can 
be understood by considering the degree of labeling of the arterial blood as it 
arrives at the tissue, and how this changes during the inflow time and/or post-
labeling delay (Figure 2). For PASL, a slab of arterial blood is inverted at TI=0, 
and subsequently undergoes T1 relaxation during the inflow time. For pCASL, 
the arterial blood is continuously inverted as it passes through the labeling 
plane, which means that all the blood has the same amount of T1 decay when 
it arrives at the tissue, irrespective of when it was labelled. However, the 
benefits of pCASL are not as large in practice as would be predicted 
theoretically, due to: (i) the inversion efficiency of the RF pulses used in 
PASL, higher than that achieved using the pCASL flow-induced adiabatic 
inversion pulse train; (ii) the sensitivity of the pCASL labeling train to off-
resonance effects, which can cause apparent regional hypoperfusion if 
different feeding arteries are affected differently; (iii) the longer arterial arrival 
times for pCASL for which the labeling plane is required to intersect major 
feeding arteries with flow in a known direction, generally placed distally to the 
PASL labeling slab. Consequently, for any given study, it is always worth 
considering the specific pros and cons of pCASL and PASL in order to choose 
the most appropriate option. 
 
The critical importance of the Post-label delay time 
An important aspect of all ASL techniques is the introduction of the PLD (or 
TI) between the end of the labeling pulse and the time of image acquisition 
(11). If the PLD is longer than the longest transit time between the tagging 
plane and the imaging volume, the ASL signal becomes insensitive to 
variations in arterial arrival time, as long as the blood and tissue T1 values are 
similar (true for grey matter but not white matter) (11, 12). This enables 
cerebral blood flow (CBF) quantification and minimizes the appearance of 
intravascular signal in the ASL images, yet at the expense of SNR, due to the 
T1 relaxation of the bolus (T1blood=1600ms at 3T). In addition, the choice of 
PLD depends on the subject’s age, with older subjects showing longer arterial 
arrival times. The recommended PLD for pediatric and adult clinical 
populations are 1500 ms and 2000 ms, respectively (10).  
 
Alterations of transit time - multi TI ASL 
Most clinically available ASL sequences use only a single delay between 
labeling and image acquisition, based on original values calculated from 
healthy young adults. In case of proximal vessel occlusion, there is a delayed 
arrival of blood in the parenchyma, which may falsely suggest a reduced 
relative CBF as estimated by ASL (Figure 3) (13) and increased ASL signal in 
the feeding arterial vessels, known as “arterial transit artifact” (14). Reduced 
cardiac output, as seen frequently in elderly populations, leads to similar 
effects, e.g. in the vascular borderzone regions (15). The use of multi-TI ASL 
sequences aim to overcome this methodological shortcoming, but due to the 
longer scan times required, they are currently not recommended in daily 
clinical practice (16, 17).  
Other parameters affecting ASL can be found in the online supplement. 
 
 
ASL in neurodegenerative diseases  
General considerations - coupling of brain perfusion and brain metabolism  
Alzheimer Dementia (AD) is the most common type of dementia. According to 
the model of neurodegeneration proposed by Jack et al. (18), brain metabolic 
alterations precede structural abnormalities during cognitive decline in AD. 
This explains the considerable interest in the assessment of brain glucose 
metabolism based on FDG-PET (18F-2-fluoro-2-deoxy-D-glucose - positron 
emission tomography) in the work-up of dementia. This technique has 
identified typical patterns of metabolic alterations in various types of dementia. 
For example, AD is typically associated with hypometabolism in bilateral 
parietal and temporal regions sparing the occipital lobe, while dementia with 
Lewy bodies also has bilateral parietal and temporal and additionally occipital 
hypometabolism (19). One disadvantage of FDG-PET is that the alterations in 
blood glucose metabolism are not specific for a given disease. This has led to 
the development of disease-specific tracers of amyloid- and tau-PET, which 
were recently introduced for clinical use. As a consequence, there is a need 
for an alternative technique, which might be used as a surrogate marker to 
replace FDG-PET in the work-up of dementia. ASL is a very promising 
alternative technique for two reasons. First, perfusion and metabolism are 
typically tightly coupled in the brain (20, 21). This perfusion-metabolism 
coupling implies that the known patterns of hypometabolism in FDG-PET in 
dementia can be transferred to patterns of hypoperfusion on ASL MRI. 
Correspondingly, there is a good correlation between brain perfusion 
measured using ASL (22-26) and brain metabolism measured by FDG PET 
(27-30), for example in the domain of MCI and AD. Second, structural MRI is 
routinely performed in many patients during the workup of cognitive decline. 
Adding an ASL sequence to the existing MR protocol is minimally demanding 
for the patient, and does not require additional radiation or use of contrast 
agents, is less costly and allows for the assessment of brain structure and 
perfusion in one imaging session. Moreover, if ASL could replace FDG PET, 
this would enable more disease-specific PET imaging with the newly available 
amyloid or tau tracers. 
 
Normal aging 
In order to be able to assess reductions in perfusion measured by ASL in 
cognitive decline, it is first necessary to understand the evolution of ASL 
imaging appearances during normal aging. A study of 44 healthy participants 
from age 4 to 78, found the highest grey matter perfusion in children (97 ± 5 
ml/100 g/minute) which had already deceased in adolescents (79 ± 3 ml/100 
g/minute). After the age of around 20, grey matter perfusion remained rather 
constant at 58 ± 4 ml/100 g/minute until the age of around 80 (31). Another 
study of 38 elderly healthy individuals (mean age 82.2 ± 3.7) found variable 
patterns of decreased and increased perfusion (32). Restom and colleagues 
compared 15 healthy young adults around 25 years of age to 12 healthy 
elderly controls around 75 years old, and found a significantly lower CBF at 
rest in the elderly (33). Rusinek et al. focused on the hippocampus during 
normal aging from 26 to 92 years due to the particular interest of this structure 
in dementia, and found no statistically significant age or gender effect (34).  
More recently, ASL was used in 148 consecutive control subjects and 65 MCI 
cases around 76 years of age (35). About half of the control participants 
developed subtle cognitive decline during follow-up. ASL imaging, performed 
at baseline, revealed decreased perfusion in the posterior cingulate cortex in 
those individuals who later developed subtle cognitive decline, indicating the 
predictive value of ASL for the earliest form of cognitive decline. Interestingly, 
the ASL pattern of those deteriorating controls was similar to MCI cases, 
indicating that these individuals were initially able to maintain an intact 
cognitive status through their cognitive reserve despite already present 
reductions in CBF.  
 
Alzheimer’s disease and mild cognitive impairment  
Alzheimer’s disease (AD) is associated with gray matter volume loss in the 
mesial temporal and parietal lobes. In earlier stages of the disease, such as 
mild cognitive impairment (MCI) or preclinical AD, atrophy can be minimal 
though metabolic imaging (FDG-PET) may already be abnormal (18, 36). 
 
ASL studies in established AD have consistently shown a reduction in CBF 
(22-25, 30, 37, 38) in a posterior parietal distribution, including the precuneus, 
posterior cingulate, angular gyrus, and superior parietal gyrus (25). The ASL 
pattern is remarkably similar (Figure 4) to the pattern of the hypometabolism 
seen with FDG-PET (39) and both modalities have similar diagnostic 
performance (38). The information from ASL persists after correction for local 
gray matter atrophy, illustrating its independent diagnostic value, although 
uncorrected ASL maps may be preferred in a clinical setting to increase the 
effect-size. Similar patterns of hypoperfusion have been observed in subjects 
with MCI, and preliminary evidence suggests that abnormal perfusion in the 
precuneus can predict conversion to AD (40), though larger studies are 
required for confirmation.  
 
Fronto-temporal lobar dementia, Lewy Body Dementia, and Vascular 
Dementia 
Less is known about the potential of ASL in dementias other than AD. In 
subjects with fronto-temporal lobar dementia, Due et al. (30) found right 
frontal hypoperfusion in 21 patients, similar to FDG-PET, while perfusion in 
parietal regions and posterior cingulate was preserved relative to AD. These 
findings were confirmed in a study comparing AD and fronto-temporal lobar 
dementia (41), with both ASL and FDG showing a clearly differentiating 
pattern in fronto-temporal lobar dementia compared to AD (Figure 4).  
 
In dementia with Lewy bodies, Taylor et al (42) found posterior hypoperfusion 
in the posterior cingulate and higher-order visual association areas in 15 
dementia with Lewy bodies patients; no comparison with AD was made. In the 
related Parkinson’s Disease Dementia disorder, Le Heron et al. (43) found the 
pattern of posterior hypoperfusion to largely overlap with AD patients, hinting 
at a similar mechanism of neurodegeneration.  
 
Vascular dementia by definition is caused by impaired cerebral perfusion and 
widespread decreases in CBF have been found especially in bilateral frontal 
and parietal areas in subjects with vascular dementia (44, 45) and subjects 
with confluent incidental white matter ischemic changes (46). The pattern 
overlaps even more with AD in post-stroke patients (47), though this may well 
be due to concomitant (unveiled) Alzheimer pathology. A related point to note 
here is the limited ability of ASL to measure white matter perfusion. Due to the 
low perfusion levels and long arterial arrival times in white matter, the SNR of 
the ASL signal is typically very low, and it is not possible to obtain reliable 
estimates of CBF unless the acquisition parameters are specifically optimized  
(48-50). 
 
 
ASL in Cerebrovascular Disease  
Early on, ASL techniques were recognized to be valuable for imaging brain 
ischemia. Indeed, following the National Institute of Neurological Disorders 
and Stroke (NINDS) trial (51) and the development of diffusion imaging, the 
potential of acquiring brain perfusion images without contrast was recognized. 
This allows perfusion imaging in patients with contraindications to IV contrast, 
such as renal failure, and simplifies the acquisition of quantitative CBF, which 
is challenging with contrast agent-based perfusion techniques, such as 
dynamic susceptibility contrast (DSC). 
 
Initial reports of ASL imaging in stroke demonstrated proof-of-principle, but 
were limited by their inability to image the entire brain (52). Since the 
widespread use of whole-brain, high SNR ASL sequences, several studies 
have shown reasonable concordance of ASL with DSC measures of perfusion 
deficit, primarily time-based parameters such as the mean transit time and 
time-to-peak of the residue function (Tmax) (Figure 5). (53-56). Vessel-
selective ASL has the additional advantage of being more sensitive to identify 
perfusion changes induced by collateral flow: (57) in stroke patients.  Routine 
ASL can also show perfusion changes in Moyamoya patients (58). It has also 
been applied to cases where treatment was initiated on the basis of the 
presence of collateral flow (59). 
 
The ability of ASL to measure severe hypoperfusion or determine perfusion in 
regions with prolonged arterial arrival times remains a critical issue for 
imaging patients with cerebrovascular disease. In these situations, there can 
be regions with a lack of ASL signal intensity in the ischemic lesion that 
render reconstruction of summary maps difficult. However, for the detectability 
of stroke, ASL techniques have been shown to be at least equivalent to DSC 
techniques, and can be used for a mismatch approach with DWI images (54, 
60). In our experience, it is particularly helpful when ASL shows normal 
perfusion or hyperperfusion (as is sometimes seen after vessel 
recanalization), since it eliminates the possibility of a diffusion-perfusion 
mismatch that would reflect tissue at-risk of infarction, thus directly affecting 
patient management. 
 
In patients with known cerebrovascular disease, alternative ASL imaging 
strategies could be considered, including long-label long post-label delay 
single time-point ASL and multi-delay ASL. The former will mitigate the 
problem of slow flow not arriving at the tissue bed by the time of imaging, 
resulting in CBF underestimation. However, differences in the decay of the 
label when it is within the blood, with its longer T1 compared with tissue, can 
lead to misinterpretation, with adequate CBF that arrives later than expected 
appearing hyperintense. Multi-delay ASL, in which ASL images with several 
post-label delay times are acquired, offers the potential to measure both 
perfusion and arterial arrival time, and use the arrival time information to 
improve the accuracy of the CBF maps. This addresses some of the problems 
of long-label long-delay ASL, but at the expense of SNR per unit time. 
Practically, this means that multi-delay ASL scans will have reduced spatial 
resolution unless scan efficiency is improved or much longer imaging times 
are accepted. One promising approach to improve the time efficiency of multi-
delay ASL is Hadamard encoding (61). Hadamard encoding is a method in 
which blocks of labeling are mixed with blocks of non-labeling, with different 
permutations of the labeling and control blocks. This method enables 
reconstruction of images with different delay times in a more time-efficient 
manner, leading to higher SNR, particularly for transit time mapping. (61, 62). 
 
ASL has also been applied to chronic cerebrovascular disease, including 
carotid stenosis and occlusion (14, 63, 64) and Moyamoya disease (58, 65-
68). Such diseases are characterized by near normal CBF, but often striking 
abnormalities of arterial arrival time, since blood arrives at the parenchyma 
through alternative pathways. For this reason, many of these studies have 
availed themselves of multi-delay ASL approaches, to correct CBF values for 
arrival time, and to map transit time abnormalities directly (Figure 6). Given 
the relatively long delays, either the use of extremely long label and post-label 
delay times or multi-delay ASL is critical for a proper perfusion measurement 
in these diseases.  This being said, even with state-of-the-art techniques, 
there are a few patients with very severe Moyamoya disease, in which ASL 
imaging of CBF is practically infeasible due to the extremely circuitious and 
delayed arrival time of the blood flow, due to loss of the magnetic label during 
the transit between the labeling region and the brain parenchyma. 
 
 
ASL in AVM and fistula  
One unexpected but useful clinical application of ASL imaging is the ability to 
identify lesions with arteriovenous shunting. Because >90% of water is 
extracted during the first pass through the capillaries, and because the mean 
dwell time of water molecules once extracted from the vascular into the 
extravascular space is several minutes, most of the labeled water decays 
within the brain parenchyma, and does not reach the veins. This leads to the 
excellent depiction of parenchymal perfusion and the absence of vascular 
signal on most ASL scans. However, if the capillary bed is absent, as in the 
two most common shunting lesions of the CNS, the arteriovenous 
malformation (AVM) and dural arteriovenous fistula (AVF), ASL signal 
appears in venous structures (69). This can be quite striking, given the high 
blood volume of the veins (Figure 7). 
 
While large AVM’s and dural AVF’s are not difficult to diagnose with routine 
anatomical MR imaging, small lesions or evolution of lesions following 
embolization therapies can be very challenging to identify. Le et al. 
demonstrated that identification of small (<2 cm) lesions was significantly 
improved if readers were allowed to view ASL in addition to conventional 
imaging (70). In fact, this may be more sensitive than conventional 
angiography, as venous signal on ASL has been seen in AVMs in the setting 
of intracranial hemorrhage where initial angiograms were negative, possibly 
due to mass effect. It has also been shown that identification of such lesions 
outside the brain, within the upper neck region, is also possible with ASL (71). 
Finally, shunting physiology has been identified in about 10% of 
developmental venous anomalies, suggesting that transitional lesions might 
be more common than is generally appreciated (72). 
 
One challenge for ASL when using venous signal to identify shunt lesions is 
that conspicuity depends on the precise timing parameters (i.e., the labeling 
duration and the PLD. While the use of recommended parameters (10) 
appears fairly sensitive for detecting most lesions, it is possible that in either 
slow or fast shunting lesions, venous ASL signal could be suboptimal or 
missed. Therefore, there is interest in multi-delay ASL, in which images at 
different labeling duration and/or post label delay are acquired as part of a 
single acquisition. While these sequences were first developed for better CBF 
quantification, the ability to optimize the sensitivity for the detection of venous 
signal is also enhanced. However, spatial resolution is reduced compared 
with single-delay ASL for a given imaging duration, and thus any gains might 
be offset by this lower resolution. ASL-based multi-delay MR angiographic 
sequences have also been developed, focusing more on direct vessel 
visualization (73). As such, these latter sequences would compete more 
directly with conventional angiography, with comparable temporal resolution 
without the associated risks.  
 
 
ASL in Epilepsy 
The main interest of ASL in the context of epilepsy is to locate a potential 
epileptogenic focus. ASL might further be helpful in the differential diagnosis 
for example in assessing for a stroke in the acute stage. During the acute 
peri-ictal period, the CBF is typically increased due to pathologic neuronal 
activity (74), while in the chronic inter-ictal period, CBF is typically reduced as 
the epileptogenic region typically is less functional and active as compared to 
the normal brain tissue (75-79). 
 
Nuclear medicine techniques such as ictal and inter-ictal SPECT and PET are 
often performed to detect metabolic changes related to epileptic activity. Since 
standard structural MR imaging is routinely performed, ASL might be of 
interest as an additional functional marker of cerebral perfusion with minimal 
additional effort. Hypoperfusion on ASL corresponds to hypoperfusion on 
interictal PET and electrophysiological data (75, 76, 80), indicating the 
potential use of ASL for epileptic focus localization (Figure 8).  
 
 
ASL in neoplasms  
Hemodynamic changes are present in many CNS neoplasms, and in general, 
CBF and cerebral blood volume (CBV) increase with tumor grade. Historically, 
much of our MR-based knowledge about these hemodynamic changes has 
been gained from DSC and dynamic contrast enhancement  (DCE) imaging 
(81-87). This has had two main consequences: (1) most literature has focused 
on relative CBV changes, because the DSC measurement of CBV is more 
straightforward compared with CBF, and (2) most of our data is of relatively 
poor spatial resolution and prone to artifacts, since the rapid passage of the 
intravascularly-confined tracer necessitates rapid, sometimes suboptimal, 
imaging. ASL cannot measure relative CBV; instead, CBF measurements are 
more straightforward. While CBV and CBF are related via the Grubb’s law 
(CBV = CBF0.38) in normal tissue (88), it is likely that this relationship is altered 
in tumors, which may form abnormal blood vessels that alter the CBV/CBF 
ratio. Also, since there is no requirement to accurately track a rapid 
intravascular bolus of contrast, the ASL experiment is more flexible, such that 
SNR, spatial resolution, amount of tolerable image distortion, and imaging 
time may be traded off against one another. Lastly, since water has high 
permeability in the normal and neoplastic tissue, there is no need with ASL 
(unlike DSC) to employ complicated leakage-correction algorithms to obtain 
quantitative results. 
 
Primary CNS Neoplasms 
GBM is the most common high-grade CNS tumor in adults, and is associated 
with high metabolism and CBF (Figure 9). Initial reports demonstrated that 
ASL and DSC show largely concordant results in terms of identifying this 
tumor, and distinguishing it from contrast-enhancing mimics (89-92). Higher 
CBF in GBM correlates with genetic markers (such as epidermal growth factor 
receptor) and is associated with shorter progression free survival time (93). 
Lower grade tumors typically demonstrate lower CBF. CBF changes may 
portent transformation to a more aggressive phenotype. In fact, some have 
suggested that CBF quantification provides a better estimate of event-free 
survival for a wide range of gliomas than does a histological grading scale 
(94). One exception to this rule of increasing CBF and tumor grade is 
oligodendroglioma, a grade 2 tumor that often demonstrates increased CBF.  
 
Secondary CNS lesions 
Most metastatic brain lesions show similar or lower glucose uptake and CBF 
compared with gray matter. However, several metastatic lesions demonstrate 
increased CBF, and share the feature of high vascularity. These include renal 
cell carcinoma (95), angiosarcoma, hemangioblastoma (96), and melanoma, 
and in these cases, ASL may be helpful (Figure 10).  
 
Assessing treatment response 
The quantitative nature of ASL has enabled studies of CBF changes over time 
or with treatment, to assess its impact on prognosis and outcome. A 
particularly important and challenging distinction to make is between radiation 
necrosis and recurrent tumor in patients with new or increasing contrast 
enhancement. Since radiation necrosis is associated typically with reduced 
CBF and most recurrent tumors demonstrate increased CBF, perfusion 
imaging may be helpful to distinguish the two entities. DSC and MR 
spectroscopy have also been used for this distinction, with some success (97-
99). ASL is likely to improve upon DSC perfusion measures, given its better 
imaging performance around resection cavities (where blood products can 
affect DSC results). It is also less sensitive to the presence of surrounding 
large vessels, which can make it challenging to quantify CBF in the actual 
lesion (Figure 11). 
 
Using clinical and imaging endpoints, Oszunar et al. (100) suggested that ASL 
is superior to FDG PET and DSC for distinguishing tumor recurrence from 
radiation necrosis in gliomas, with a sensitivity of 94%. In the early time period 
following resection (< 4 wks), where any contrast enhancement is probably 
due to pseudo-progression, again ASL appeared more useful than DSC (101). 
Another technique that can evaluate both initial presentation and treatment 
changes in tumors is DCE imaging, in which the rate of contrast agent 
leakage is estimated.  
 
 
ASL in psychiatric and other neurologic disorders 
An increasing number of investigations have assessed ASL in various 
psychiatric and neurologic diseases. 
 
Depression 
In a study of 25 medication-naive adolescents with major depressive disorder, 
Ho et al., found a complex pattern of hypoperfusion in frontal, limbic, 
paralimbic, and cingulate yet hyperperfusion within the subcallosal cingulate, 
putamen, and fusiform gyrus (102). The authors conclude that adolescents 
with major depressive disorder differ in their baseline perfusion in executive, 
affective, and motor networks. Several studies assessed adults with 
depression and found reduced CBF in the default mode network (103) (a 
brain network initially described based on CBF maps (104) that is consistently 
found in resting fMRI studies (105)) as well as bilateral subgenual anterior 
cingulate cortex, left prefrontal dorso-median cortex, and left subcortical areas 
(putamen, pallidum and amygdala) (106). Lui et al. further subdivided patients 
with refractory depressive disorder from patients with non-refractory 
depressive disorder (107). Non-refractory depressive disorder subjects versus 
controls had reduced CBF in the left prefrontal cortex and increased CBF 
mainly in the limbic-striatal areas. Conversely, refractory depressive disorder 
subjects had decreased CBF predominantly in the bilateral frontal and 
bilateral thalamic regions. The direct comparison of the two depressive 
disorder groups further revealed higher CBF mainly in the limbic-striatal 
areas. Finally, late-life depression is associated with increased white matter 
CBF yet conserved grey matter CBF (108). In conclusion, these results 
indicate that different subtypes of depression are associated with specific 
patterns of CBF alterations, which furthermore change over the lifespan. 
 
Psychosis 
Patients with schizophrenia compared to controls had a pattern of increased 
CBF in left putamen/superior corona radiata and right middle temporal gyrus 
yet decreased CBF in bilateral precuneus and middle frontal gyrus (109). 
Moreover, a sub-division into patients according to symptomatology revealed 
an association of negative symptoms (including difficulties in thinking or 
coming up with ideas, decreased ability to start initiate tasks, lowered levels of 
motivation or drive, lack of interest in other people) with reduced CBF in 
bilateral superior temporal gyrus, cingulate gyrus, and left middle frontal 
gyrus, and an association of positive symptoms (including delusions, 
hallucinations, disorganized speech or behavior) with increased CBF in 
cingulate gyrus and superior frontal gyrus and decreased CBF in precentral 
gyrus/middle frontal gyrus. Astudy by Ota et al. found a different pattern of 
reduced relative CBF in the left prefrontal and bilateral occipital cortices 
compared to the healthy volunteers (110). Finally, Kindler et al. observed 
decreased mean CBF in the frontal and temporal regions and significantly 
increased default mode network connectivity in the precuneus in 
schizophrenia patients. Currently it is impossible to disentangle whether these 
observed differences in ASL based alterations in CBF in schizophrenia 
patients are due to different stages and subtypes of the disease, 
methodological, or a combination of both.  
 
Posttraumatic stress disorder 
Posttraumatic stress disorder (PTSD) has attracted considerable interest in 
recent years. Schuff et al. assessed 17 male veterans with PTSD and 
observed increased relative CBF in primarily right parietal and superior 
temporal cortices (111). Li et al. implemented a more complex setup in 
veterans nearly 20 years after the 1991 Gulf War, contrasting baseline ASL 
with a physostigmine challenge (112). Physostigmine significantly decreased 
hippocampal relative CBF in controls and veterans with syndrome 1 (impaired 
cognition), yet significantly increased hippocampal relative CBF in veterans 
with syndrome 2 (confusion-ataxia) and 3 (central neuropathic pain), 
suggesting that ASL might differentiate subtypes of PTSD types. 
 
Mild traumatic brain injury 
Mild traumatic brain injury (MTBI) is another entity that has attracted 
considerable interest, notably related to the discussion of brain alterations in 
professional football and soccer players. Conventional MRI sequences are not 
sensitive enough to detect structural brain changes, and consequently an 
increasing number of investigations used advanced imaging techniques such 
as ASL or diffusion weighted imaging (113). In 2009, Ge et al. demonstrated 
reduced CBF in bilateral thalamus in patients with MTBI (114). Later on, the 
same group extended these findings by combining ASL to assess CBF and 
diffusion tensor (DTI) and diffusion kurtosis (DKI) imaging to assess white 
matter, again detecting substantial alterations in both perfusion and white 
matter integrity in MTBI patients focusing on the thalamus (113). Interestingly 
these alterations persisted more than 9 months after injury. Doshi et al. 
assessed the acute stage of MTBI and found increased in regional CBF in the 
left striatum, and in frontal and occipital lobes (115). Finally, Wang et al. 
investigated pediatric MTBI and found reduced CBF in bilateral frontotemporal 
regions (116). In summary, these results indicate that ASL might be a 
sensitive marker to assess MTBI-related alterations in the brain, which are not 
detectable by conventional MRI techniques. The discrepancies between these 
studies in turn also implies the need for strict standardization of both data 
acquisition and data analysis. 
 
Pain and migraine 
Owen et al. investigated healthy volunteers during painful thermal stimulation 
and observed bilateral CBF changes including the insula, secondary 
somatosensory, and cingulate cortices, as well as the supplementary motor 
area, in an attempt to quantify pain-induced perfusion alterations in the brain 
(117). A similar approach by Maleki et al. found alterations in relative CBF in 
somatosensory cortex, anterior cingulate cortex, anterior insula, 
hippocampus, amygdala, thalamus, and precuneus. Taken together, these 
studies suggest that ASL might be used as an operator-independent marker 
in subjective pain syndromes. Accordingly, Liu et al. observed in patients with 
postherpetic neuralgia, a pattern of increased CBF in left striatum, right 
thalamus, left primary somatosensory cortex, left insula, left amygdala, left 
primary somatomotor cortex, and left inferior parietal lobule yet decreases 
CBF in the frontal cortex (118). 
Migraine is of particular interest with respect to ASL imaging. Although 
controversial, it is thought that migraine attacks might involve vascular 
dysregulation. Correspondingly, mapping the brain CBF by ASL might reveal 
insights into the pathophysiology of migraine. Kato et al. performed ASL 
imaging in a patient during a migraine attack, after treatment with a triptan and 
in the attack-free period (119). During the migraine attack, CBF was reduced 
in bilateral median thalamic areas including hypothalamus and increased in 
the frontal cortex as compared to baseline. 30 minutes after treatment 
initiation, CBF perfusion improved in thalamus and hypothalamus. A case 
series sby Pollock et al. demonstrated regional cerebral hyperperfusion in 3/ 
11 patients during a headache episode that corresponded to previous aura 
symptoms (120). While these pilot studies demonstrated interesting 
preliminary findings, larger scale studies are clearly needed to investigate 
whether ASL might contribute to a better understanding of the 
pathophysiology of pain, notably a potential vascular component of migraine.  
 
Novel extensions of ASL  
Super-selective ASL to map vascular territories (aka selective territory 
mapping) 
Contrary to contrast-enhanced CT perfusion or DSC, ASL provides the 
opportunity to selectively label vascular territories, such as left carotid, right 
carotid and vertebrobasilar territories (121, 122) or even their more distal 
branches. This can be of interest from a scientific perspective, for example, to 
assess the impact of vascular variants of the circle of Willis on perfusion of the 
brain tissue, such as caudate and lenticular nucleus and thalamus (123). 
More importantly, territorial ASL might have clinical value, e.g., to determine 
whether multiple acute vascular lesions are in the same vascular territory as 
argument for distant cardio-embolic events in several vascular territories 
versus local stenotic origin for a single vascular territory or for neurosurgical 
planning of e.g. aneurysm clipping or tumor resection. 
 
Cerebrovascular Reserve Imaging 
The ability of an organ to adapt to a physiological challenge, particularly one 
that stresses its limits, can be measured using reserve studies. Such imaging 
may unmask deficits that are not apparent on routine images. Myocardial 
stress-rest imaging following either exercise or pharmaceutical vasodilatory 
challenge has been a mainstay of cardiac imaging for decades. A similar 
cerebrovascular “stress test” can be performed, using either physiological 
(i.e., CO2 inhalation or breath-hold) and pharmaceutical vasodilation. In 
particular, acetazolamide, a carbonic anhydrase inhibitor, causes 20-50% 
CBF increase in normal subjects. However, patients in whom the 
cerebrovasculature is already maximally dilated to maintain baseline CBF 
may not be able to augment their CBF further in response to an 
acetazolamide challenge. In fact, those with very severe disease may 
demonstrate reduced CBF in response to challenge, a phenomenon known as 
cerebrovascular steal. 
 
Limited data using non-MRI techniques, including transcranial Doppler, 
SPECT, and PET suggest that demonstration of poor reserve is an important 
risk factor for subsequent cerebrovascular events (124). Given its non-
invasive nature, ASL is an ideal method to image CBF changes in response to 
a challenge (14, 125). Since these patients may have large artery stenosis or 
occlusion, the use of multi-delay ASL to quantify both arrival time and CBF is 
recommended. An example of reserve imaging with multi-delay ASL in a 
patient with Moyamoya disease with cerebrovascular steal of the bilateral 
anterior circulation is shown in Figure 12. 
 
Functional MRI and ASL  
Functional MRI studies generally rely on the blood oxygen level-dependent 
(BOLD) effect (126) and the neurovascular coupling (127). Because fMRI 
does not directly measure neuronal activation but the indirect vascular 
response, alterations of the neurovascular coupling might influence the 
resulting fMRI BOLD signal, for example already in normal aging (33, 128). 
The combination of ASL and fMRI might disentangle vascular and neuronal 
contributions of the BOLD response (128).  
Moreover it is possible to use the time-series of the ASL raw data to calculate 
fMRI activation maps (129) or resting-state functional connectivity networks 
known from fMRI (105). Although the quality of these ASL based results is 
generally below that of classic EPI BOLD fMRI, this might be interesting from 
a clinical perspective as ASL can be used to calculate relative CBF maps and 
resting-state functional connectivity networks of a reasonable quality without 
additional cost or scanning time which is particularly helpful in elderly patients 
(Figure 13). 
 
 
Conclusions  
Although ASL has been around for over two decades, it only recently began to 
make the transition from a research tool to clinical use due increasing 
awareness of radiologists and clinicians of its capability and technical 
improvements that have made this approach more reliable and available as 
product sequences on MRI platforms. For many diseases, including dementia, 
vascular diseases, neoplasms, and various psychiatric diseases, ASL 
provides additional and complimentary information to that available from 
structural MRI imaging. Current methodological developments aim to increase 
the robustness and decrease inter-scanner variability of CBF estimation. 
 
 
 
 
Online supplement 
Quantification of CBF and local alterations in CBF estimation  
A number of investigations directly compared CBF estimation in ASL to 15O 
H2O PET as reference standard (16, 130, 131) or combined PET-MRI 
technology (132, 133). Overall, these studies showed good correlations 
between CBF estimation in ASL and PET. Furthermore, most studies showed 
a systematic bias of relative CBF estimation in ASL. In addition, the 
placement of the imaging slab substantially changes the relative CBF 
estimation in ASL and the correlation with water PET (134) indicating the 
need for rigorous standardization of image acquisition. Moreover, the direct 
comparison between two different ASL sequences (135) demonstrated a good 
global correspondence between the relative CBF estimated by both 
techniques but also pointed to systematic local differences between the 
results, even if acquired with both sequences during the same session. Note 
that differences in the calibration method used explained most of the results in 
this case. It is likely that different ASL sequences on different MRI machines 
with different hardware will show even larger differences in the estimated 
relative CBF maps. This implies that individual ASL sequences might have 
variations in local sensitivity, which in turn highlights the need for strict 
standardization of image acquisition and calibration of each ASL sequence, 
e.g. using flow phantoms. This is of particular interest in neurodegenerative 
diseases, as disease-related alterations in relative CBF, notably at early 
stages of the disease, are well in the range of normal variability between 
different ASL sequences even when these sequences (135)  are performed 
with recently recommended protocols (10). 
 
Partial volume correction 
Another potential issue with ASL is the relatively low spatial resolution 
typically used (on the order of a few millimeters in each direction), which 
makes it nearly impossible to obtain any relative CBF measure located 
uniquely within the cortical ribbon (136). Due to the large difference in 
perfusion values between gray and white matter (in a ratio of 3:1), even a 
small amount of white matter within a voxel located primarily within gray 
matter will lead to an artificially low perfusion value. For this reason, a series 
of post-processing techniques have been developed, using the assumption 
that the relative CBF only varies slowly within the gray matter (and white 
matter) to separate the contributions from each tissue type to the perfusion 
maps (136). This method might be particularly important when focusing on 
statistical differences between patients presenting with gray matter atrophy, 
enabling reduced perfusion to be differentiated from an increased proportion 
of white matter relative CBF in a thinning cortical ribbon (though one could 
argue from a pragmatic viewpoint that it does not matter why perfusion is 
abnormally low). 
 
Reproducibility, Inter-individual Variability and SNR  
For many years, developments of ASL focused on methodological 
improvements and did not investigate the important issue of intra- and inter-
subject reproducibility. One of the first large-scale reproducibility studies was 
published in 2010, based on the QUASAR sequence (137). The mean gray 
matter CBF was determined to be 47.4±7.5 ml/100 g/min in that study, with a 
standard deviation between the different sites SDs = 1.8 (CI: 1.0–3.3) ml/100 
g/min, a between-subject standard variation of 5.5 (CI: 5.0–6.2) ml/100 g/min 
and a within-subject standard deviation of 4.7 (CI: 4.5–5.0) ml/100 g/min with 
a corresponding repeatability of 13.0 ml/100 g/min. Such results - based on 
more than 280 subjects - showed that using a single sequence in different 
research centers was possible, and demonstrated that the reproducibility 
achieved by ASL was comparable to equivalent nuclear medicine methods 
(137). 
Note that for this study all data were acquired on identical 3T scanners from a 
single manufacturer. Since then, numerous other studies have been 
published, comparing different sequences on a single manufacturer (138), 
near identical sequences on different manufacturers (139), and combinations 
in between. The general results confirm the same level of reproducibility, 
within and between subject standard deviations as originally found in the 
QUASAR reproducibility study (137). Potential site-specific variations in gray 
matter CBF values might actually be problematic, and current research is 
focusing on eliminating such differences to avoid bias in future multicenter 
trials (10). 
 
1.5T versus 3T 
Since ASL is a low SNR technique, it benefits substantially from any possible 
increase in SNR. SNR increases approximately linearly with field strength, 
and therefore 3T is expected to increase SNR by a factor of two relative to 
1.5T (4). In addition, T1 also increases with field strength, resulting in a slower 
disappearance of the labeled blood at 3T (T1blood = 1.65s) than at 1.5T 
(T1blood=1.35s). Both effects will act together to increase SNR, and the ASL 
white paper therefore recommended the use of higher field strengths for ASL 
(10). 
 
2D versus 3D acquisition schemes 
The most widely used image acquisition scheme for ASL is EPI, which is a 
multi-slice 2D technique. The intrinsic SNR advantage of 3D acquisition 
schemes renders them an attractive alternative for the imaging module of ASL 
sequences. Various approaches have been implemented, including 3D 
GRASE (140), 3D spiral FSE (9) and 3D EPI (141). Although 3D image 
readout methods have some challenges regarding image acquisition speed 
and resolution, overall, they are advantageous for ASL, for several reasons. In 
addition to the intrinsic SNR increase gained from exciting the entire volume 
with each read-out, they have the additional advantage that it is possible to 
define a precise time at which the whole volume is imaged. This contrasts 
with 2D techniques such as multi-slice EPI, where each brain slice is acquired 
at a different time, and consequently has a different PLD. As well as 
simplifying CBF quantification and avoiding any potential saturation of 
inflowing blood by previous slice excitation pulses, a single TI/PLD enables 
optimal background suppression to be achieved over the whole imaging slab, 
therefore providing higher SNR and improved data quality for clinical use. 
 
Variation of ASL CBF due to caffeine and other vasoactive substances 
Vasoactive substances are frequently prescribed notably in the elderly, and 
may alter CBF. It may be less appreciated that even substances such as 
caffeine, which are widely distributed in beverages such as cola or coffee, 
significantly reduce the CBF estimated in ASL imaging, by about 20% in 
young adults (142) and even more in elderly controls (by approximately 23-
25%) and mild cognitive impairment (MCI) (~30%) (143, 144). Disease-related 
alterations in relative CBF, for example in dementia, are considerably smaller 
than caffeine-induced reduction of global CBF. Consequently, vasoactive 
substances must be considered as a potential confound for quantitative 
analyses of relative CBF, and compensation strategies such as normalizing 
with respect to whole brain average relative CBF might be worth considering, 
depending on the clinical context. These observations indicate that in 
particular in conditions in which relatively subtle alterations of relative CBF are 
expected, notably dementia or psychiatric diseases, patients should be asked 
to refrain from caffeine ingestion 4-6 h prior to MR imaging. 
 
Decreased cardiac output / alterations in hematocrit  
Decreased cardiac output might lead to delayed arrival of the labeled blood, 
which might be misinterpreted as reduced perfusion. Therefore, care needs to 
be taken when scanning patients with potential cardiac issues, as the entire 
circulation system might be affected. Other systemic alterations might directly 
affect brain perfusion, such as a change in hematocrit. Indeed, the normal 
physiological response to a reduced amount of oxygen carrying capacity will 
be to increase blood flow systemically throughout the body, and in particular 
to the most important organs, such as the brain. The problem for ASL is that a 
reduced hematocrit will also be accompanied by an increase in blood 
relaxation time T1b (145, 146), leading to a potential overestimation of 
perfusion measured by ASL, as the label will disappear at a slower rate than 
assumed. Note that these issues are particularly relevant in neonates (147) 
and in patients with erythrocyte-related diseases, such as Sickle Cell Disease 
(148). 
 
 FIGURE 1  
 
ASL labeling schemes: (a) in PASL, an inversion slab is placed proximal to 
the imaging volume to label blood in the arterial feeding vessels supplying the 
brain. The pulse is short (~10ms) and all the blood is inverted simultaneously; 
(b) in pCASL, the inflowing arterial blood is continuously inverted as it flows 
through the labeling plane, via a process known as flow-induced adiabatic 
inversion. The pCASL labeling pulse train is typically applied for a period of 
~1-2s. 
 
FIGURE 2  
 
Differences in labeling degree of ASL bolus for PASL (left column) and 
pCASL (right column). The top row shows the temporal profile of the bolus 
(1=fully inverted; 0=fully relaxed). Since the PASL inversion slab is inverted at 
a single point in time (t=0 on this graph), all the inflowing arterial blood 
undergoes the same amount of T1 recovery at all time points after this. In 
pCASL, blood is labeled as it flows through the inversion plane and recovers 
en route to the imaging volume. A-D shows the degree of labeling remaining 
at several time points after the (start of) labeling (t=0): A t=0; B t = arterial 
arrival time (ATT); C t = bolus duration (τ); D t = ATT + τ. Color scale 
represents the range from fully inverted (red) to fully relaxed (blue). It can be 
seen that the pCASL labeling process produces a bolus with a higher overall 
degree of inversion than PASL, resulting in a higher intrinsic SNR for pCASL. 
 
 
Figure 3  
 
Example of an underestimation of relCBF in ASL due to a proximal vessel 
stenosis: The estimated relative CBF based on DSC perfusion is within 
normal limits (A). In contrast, the relative CBF estimated using a standard 
single TI ASL sequence demonstrates a marked reduction in the left anterior 
and middle cerebral artery territories (B). The origin of this discrepancy is the 
increased perfusion delay, illustrated in the DSC-derived delay map (C), 
which exactly matches the altered perfusion in ASL, due to the presence of a 
high-grade stenosis of the left internal carotid artery (time of flight, D). The 
underlying principle is explained in E. The normal perfusion time-series of 
DSC imaging (solid black line) is shifted to the right due to the presence of a 
proximal vessel stenosis and slower collateral flow (dotted line). As DSC 
imaging acquires an entire time-series, this shift in the bolus arrival simply 
cases a shift of the estimated curve, and the relative CBF can be accurately 
estimated in DSC. In contrast, a single TI ASL sequence with a standard TI 
(indicated by the vertical line) will under-estimate the true perfusion simply 
because it is too early with respect to the peak of the perfusion curve.  
 
 
FIGURE 4 Examples of dementia. 
 
Transverse FDG and ASL images of a healthy individual (first row, male, age 
57, mini mental state examination 30), patient with AD (second row, male, age 
52, MMSE 19), and patient with fronto-temporal lobar dementia (third row, 
female, age 53, MMSE 26). Functional images show predominant prefrontal 
abnormalities in FTD and parietal abnormalities in AD. 'Red color' reflects 
normal metabolism and perfusion. 
 
 
FIGURE 5  
 
50 year-old woman presenting with stroke with 14 hrs of right hemiparesis and 
aphasia, national institute of health stroke scale (NIHSS) of 9 at the time of 
imaging. Patient later found to have extracranial left internal carotid artery 
dissection. (A) demonstrates irreversibly damaged tissue on DWI within the 
left caudate and putamen. Using a multidelay ASL sequence capable of 
acquiring both (B) CBF and (C) arterial transit time images, a larger region of 
perfusion abnormality is identified. (D) The region of perfusion abnormality 
(time to the maximum of the residue function, Tmax) on conventional dynamic 
susceptibility contrast images is concordant with the findings on the ASL 
images. 
 
Figure 6  
 
Example of multi-delay ASL imaging.  A fixed labeling duration of 2000 ms is 
used, but on subsequent images, different post-label delays (PLDs) ranging 
from 700 to 3000 ms are employed, yielding ASL difference (control – label) 
images as shown in (a).  From this data, and the use of general kinetic 
modeling, one can simultaneously measure (b) an arrival-time corrected CBF 
and (c) the arterial arrival time itself. In this patient, there is near symmetric 
CBF but clear arterial arrival delay in the right hemisphere, as shown by the 
higher values on the arrival time map. 
 
 
FIGURE 7  
 
51 year-old man with exertional headaches, imaged at 1.5T with an AV fistula. 
(A) T2 images demonstrate very subtle flow voids in the inferior frontal lobe 
(arrows). (B) ASL images demonstrate very bright linear signal in the region of 
the right inferior frontal lobe, which extends to the right cavernous sinus, 
indicative of an arteriovenous shunt lesion. (C) Collapsed and (D) source MR 
angiographic images confirm the presence of an ethmoid dural fistula, which 
was recognized only after the observation of the abnormal ASL signal within 
the venous structures draining the fistula. This case also demonstrates that 
while 3T is preferable to 1.5T, relevant clinical information can be obtained 
with ASL at 1.5T. 
 
FIGURE 8  
 
Comparison of ASL MRI and 18FDGPET in epilepsy. Each vertical column 
represents a single patient’s imaging studies. A: preoperative axial T1 
weighted MRI. B: raw 18FDG PET scan images. C: raw pASL CBF maps. D: 
image fusion of T1MRI and 18FDG PET. E: image fusion of T1MRI and pASL. 
Arrows indicate regions of focal cortical dysplasia that are epileptogenic. 
Reprinted with permission from (80). 
 
 
FIGURE 9  
 
78 year old man with unresectable anaplastic astrocytoma (WHO Grade III), 
seen on (A) post-contrast T1-weighted and (B) FLAIR images. (C) ASL 
demonstrates increased CBF in the region of the tumor. (D) Increased CBV is 
also visible on bolus dynamic susceptibility contrast (DSC) imaging (black 
arrow), though it is more difficult to appreciate due to the extensive number of 
arterial and venous vessels that surround the tumor. The findings of high CBF 
are characteristic of high-grade (Grades III and IV) glial neoplasms. 
 
FIGURE 10  
 
T2 (A), post-contrast T1 (B), and ASL (C) images in a 40 yo man with von 
Hippel Lindau disease and multiple hemangioblastomas, status post multiple 
prior surgeries. Arrows point out the extremely high CBF measured with ASL 
even in very small lesions. 
 
 
FIGURE 11  
 
57 yo man with lung cancer brain metastasis, 15 months status post 
resection, radiation, and chemotherapy. (A) Axial T1Gd shows a new 
enhancing lesion with (B) axial FLAIR demonstrating extensive vasogenic 
edema in the region of the resection cavity. (C) ASL demonstrates no 
increase in CBF in this region, similar to findings on (D) FDG PET. These 
findings were considered to represent radiation necrosis and the patient is 
being followed serially rather than with re-resection. 
 
 
FIGURE 12  
 
29 year-old woman with bilateral Moyamoya disease. Both FLAIR (A) and 
diffusion-weighted images (B) show evidence of prior infarcts in the deep 
white matter on the left side. Multi-delay ASL images acquired at baseline 
demonstrates normal CBF in the bilateral anterior circulation (C). However, 
imaging 10 min following 1 g of IV acetazolamide (D) demonstrates the 
expected CBF increase in the posterior circulation, but marked reduction in 
CBF in both anterior circulations, compatible with cerebrovascular steal. This 
finding has been associated with a high risk of subsequent cerebrovascular 
events and prompted bilateral direct superficial temporal artery-middle 
cerebral artery  bypass. 
 
 
FIGURE 13  
Functional connectivity analysis on the ASL raw-data in 154 healthy elderly 
controls and 66 mild cognitive impairment (MCI) cases. Note that for 
illustrative purposes, the raw ASL data were directly analyzed using tensorial 
independent component in FSL (www.fmrib.ox.ac.uk/fsl/). The spatial 
representation of one of the independent components is illustrated in A. The 
on-off labeling pattern of the raw ASL data is clearly visible in the 
corresponding temporal representation in B. Adding the known prior 
knowledge of the on-off time-course could further improve the resulting 
functional connectivity networks. 
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Figure 1 ASLarterial spin labeling labeling schemes. A, In PASLpulsed ASL, an inversion slab is placed proximal to the imaging volume to
label blood in the arterial feeding vessels supplying the brain. The pulse is short (∼10 msec) and all the blood is inverted simultaneously. B, In
PCASLpseudocontinuous ASL, the inflowing arterial blood is continuously inverted as it flows through the labeling plane by means of a process
known as flow-induced adiabatic inversion. The PCASLpseudocontinuous ASL labeling pulse train is typically applied for a period of
approximately 1–2 seconds.
,
.
Figure 2 Differences in labeling degree of ASLarterial spin labeling bolus for PASLpulsed ASL (left column) and PCASLpseudocontinuous ASL (right
column). The top row shows the temporal profile of the bolus (1 = fully inverted; 0 = fully relaxed). Since the PASLpulsed ASL inversion slab is inverted at a
single point in time (t = 0 on this graph), all the inflowing arterial blood undergoes the same amount of T1 recovery at all time points after this. In
PCASLpseudocontinuous ASL, blood is labeled as it flows through the inversion plane and recovers en route to the imaging volume. A–D show the degree of
labeling remaining at several time points after the start of labeling (t = 0): A, t = 0; B, t = arterial arrival time (ATT); C, t = bolus duration (τ); D, t = ATT + τ.
Color scale represents the range from fully inverted (red) to fully relaxed (blue). It can be seen that the PCASLpseudocontinuous ASL labeling process
produces a bolus with a higher overall degree of inversion than does the PASLpulsed ASL, resulting in a higher intrinsic SNRsignal-to-noise ratio for
PCASLpseudocontinuous ASL.
Figure 3 Example of an underestimation of relative CBFcerebral blood flow (relCBF) in ASLarterial spin labeling due to a proximal vessel stenosis. A, The estimated relative CBFcerebral blood
flow based on DSCdynamic susceptibility contrast perfusion is within normal limits. B, In contrast, the relative CBFcerebral blood flow estimated by using a standard single–inflow-time ASLarterial spin
labeling sequence demonstrates marked reduction in the left anterior and middle cerebral artery territories. The origin of this discrepancy is the increased perfusion delay, illustrated on, C,
DSCdynamic susceptibility contrast-derived delay map, which exactly matches the altered perfusion in ASLarterial spin labeling due to the presence of a high-grade stenosis of the left internal carotid
artery on, D, time-of-flight (TOF) image. The underlying principle is explained in E. The normal perfusion time series of DSCdynamic susceptibility contrast imaging (solid black line) is shifted to the
right due to the presence of a proximal vessel stenosis and slower collateral flow (dotted line). DSCdynamic susceptibility contrast imaging acquires an entire time series, this shift in the bolus arrival
simply causes a shift of the estimated curve, and the relative CBFcerebral blood flow can be accurately estimated in DSCdynamic susceptibility contrast. In contrast, a single–inflow-time ASLarterial
spin labeling sequence with a standard inflow time (indicated by the vertical line) will underestimate the true perfusion simply because it is too early with respect to the peak of the perfusion curve.
Figure 4 Examples of dementia. Transverse FDGfluorine 18 fluorodeoxyglucose and ASLarterial spin labeling images of, A, a healthy individual (male;
age, 57 years; Mini-Mental State Examination [MMSE] score, 30), B, patient with ADAlzheimer disease (male; age, 52 years; MMSE score, 19), and, C, patient
with frontotemporal lobar dementia (female; age, 53 years; MMSE score, 26). Functional images show predominant prefrontal abnormalities in FTD and
parietal abnormalities in ADAlzheimer disease. Red color reflects normal metabolism and perfusion.
Figure 5 Images in 50-year-old woman presenting with stroke, with 14 hours of right hemiparesis and aphasia, National Institutes of Health Stroke Scale
score of 9 at the time of imaging. Patient was later found to have extracranial left internal carotid artery dissection. A, Diffusion-weighted images demonstrate
irreversibly damaged tissue within the left caudate and putamen. By using a multidelay ASLarterial spin labeling sequence capable of acquiring both, B,
CBFcerebral blood flow and, C, arterial transit time images, a larger region of perfusion abnormality is identified. D, Conventional DSCdynamic susceptibility
contrast images show the region of perfusion abnormality (time to the maximum of the residue function) is concordant with the findings on ASLarterial spin
labeling images.
Figure 6 Example of multidelay ASLarterial spin labeling imaging. A fixed labeling duration of 2000 msec is used, but on subsequent images, different
postlabel delays (PLD) ranging from 700 to 3000 msec are used, yielding ASLarterial spin labeling difference (control label) images as shown in A. From these
data, and the use of general kinetic modeling, one can simultaneously measure, B, an arrival-time–corrected CBFcerebral blood flow and, C, the arterial arrival
time itself. In this patient, there is near symmetric CBFcerebral blood flow but clear arterial arrival delay in the right hemisphere, as shown by the higher values
on the arrival time map.
Figure 7 Images in 51-year-old man with exertional headaches and an arteriovenous fistula imaged at 1.5 T. A, T2-weighted images demonstrate very
subtle flow voids in the inferior frontal lobe (arrow). B, ASLarterial spin labeling images demonstrate linear high signal intensity (arrows) in the region of the
right inferior frontal lobe, which extends to the right cavernous sinus, indicative of an arteriovenous shunt lesion. C, Collapsed and, D, source MR angiographic
images confirm the presence of an ethmoid dural fistula (arrow), which was recognized only after the observation of the abnormal ASLarterial spin labeling
signal within the venous structures draining the fistula. This case also demonstrates that while 3 T is preferable to 1.5 T, relevant clinical information can be
obtained with ASLarterial spin labeling at 1.5 T.
Figure 8 Comparison of ASLarterial spin labeling MR imaging and FDGfluorine 18 fluorodeoxyglucose PET in epilepsy. Each column represents imaging
studies of a single patient. A, Preoperative axial T1-weighted MR images. B, Raw FDGfluorine 18 fluorodeoxyglucose PET images. C, Raw PASLpulsed ASL
CBFcerebral blood flow maps. D, Image fusion of T1-weighted MR imaging and FDGfluorine 18 fluorodeoxyglucose PET. E, Image fusion of T1-weighted MR
imaging and PASLpulsed ASL. Arrows indicate regions of focal cortical dysplasia that are epileptogenic. Numbers 1–5 refer to different patients. (Reprinted,
with permission, from reference 80.)
Figure 9 Images in 78-year-old man with unresectable anaplastic astrocytoma (arrow) (World Health Organization Grade 3), seen on, A, postcontrast
T1-weighted and, B, FLAIR images. C, ASLarterial spin labeling image demonstrates increased CBFcerebral blood flow (arrow) in the region of the tumor. D,
Increased cerebral blood volume (arrow) is also visible on bolus DSCdynamic susceptibility contrast image, though it is more difficult to appreciate due to the
extensive number of arterial and venous vessels that surround the tumor. The findings of high CBFcerebral blood flow are characteristic of high-grade (grades
III and IV) glial neoplasms.
Figure 10 A, T2-weighted, B, postcontrast T1-weighted, and C, ASLarterial spin labeling images in a 40-year-old man with von Hippel Lindau disease and
multiple hemangioblastomas after multiple prior surgeries. Arrows point to the extremely high CBFcerebral blood flow measured with ASLarterial spin labeling
even in very small lesions.
Figure 11 Images in 57-year-old man with lung cancer brain metastasis 15 months after resection, radiation, and chemotherapy. A, Axial T1-weighted
gadolinium-enhanced image shows a new enhancing lesion, with, B, axial fluid-attenuated inversion recovery image demonstrating extensive vasogenic edema
in the region of the resection cavity. C, ASLarterial spin labeling image demonstrates no increase in CBFcerebral blood flow in this region, similar to findings
on, D, FDGfluorine 18 fluorodeoxyglucose PET image. These findings were considered to represent radiation necrosis and the patient is being followed serially
rather than with re-resection.
Figure 12 Images in 29-year-old woman with bilateral Moyamoya disease. Both, A, fluid-attenuated inversion recovery and, B, diffusion-weighted images
show evidence of prior infarcts in the deep white matter on the left side. C, Multidelay ASLarterial spin labeling image acquired at baseline shows normal
CBFcerebral blood flow in the bilateral anterior circulation. D, However, image obtained 10 minutes after intravenous administration of 1 g of acetazolamide
demonstrates the expected CBFcerebral blood flow increase in the posterior circulation but marked reduction in CBFcerebral blood flow in both anterior
circulations, compatible with cerebrovascular steal. This finding has been associated with a high risk of subsequent cerebrovascular events and prompted
bilateral direct superficial temporal artery-middle cerebral artery bypass.
Figure 13 Functional connectivity analysis of ASLarterial spin labeling raw data in 154 healthy elderly control subjects and 66 cases with mild cognitive
impairment. Note that for illustrative purposes, the raw ASLarterial spin labeling data were directly analyzed by using tensorial independent component in FSL
(<a href="http://www.fmrib.ox.ac.uk/fsl/" target="_blank">www.fmrib.ox.ac.uk/fsl/</a>), an established technique optimized for functional MR imaging analysis.
A, Spatial representation of one of the independent components. B, The on-off labeling pattern of the raw ASLarterial spin labeling data is clearly visible on the
corresponding temporal representation. Currently ongoing methodological adaptation and optimization to the specific properties of ASL data, such as
implementing the known prior knowledge of the on-off time course, will improve the quality of ASL-derived functional connectivity networks.
